Stay updated on Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record is now available, showing the completed trial’s design, eligibility criteria, locations, interventions, and safety and efficacy outcomes instead of an error page.
    Difference
    64%
    Check dated 2026-11-08T14:42:32.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now shows revision v3.8.0 instead of v3.7.2. The study record remains unavailable and displays a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T15:53:35.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates.
    Difference
    1%
    Check dated 2026-10-25T15:52:13.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T20:52:27.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer's revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T20:56:57.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, indicating the record is inaccessible; this reflects a site-access issue rather than a change to trial details.
    Difference
    19%
    Check dated 2026-09-20T19:55:50.000Z thumbnail image

Stay in the know with updates to Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page.